Results 211 to 220 of about 22,763 (264)

Behavioural and social drivers of immunisation among zero dose children in pastoralist communities of Ethiopia: a qualitative study. [PDF]

BMJ Open
Biadiglgn MT, Gelana N, Girma E, Abebe F, Mon HS, Tadesse Y, Ayalew Kokebie M, Gedlu T, Alemayehu H, Bikes T, Eshetu Y, Kasaye M, Endale A, Sharma R, Getachew H.   +14 more
europepmc   +1 more source

Caregiver and healthcare professional perspectives on drivers of routine immunisation uptake in East New Britain, Papua New Guinea: a qualitative study. [PDF]

BMJ Public Health
Dalton M, Pomat W, Sanderson B, Melepia P, James HA, Burangat D, Duwaba L, Willie D, Paivu B, Kiromat P, Stanley E, Waramin E, Laman M, Walker S, Homer C, Robinson LJ, Scoullar MJL, Vaccher S, Danchin M.   +18 more
europepmc   +1 more source

Effectiveness of interventions to increase vaccine uptake: component network meta-analysis.

BMJ
Davies SR, Davies AL, Higgins JPT, Caldwell DM, Thornton ZA, Aiton E, Ali I, Dawson S, McGrath C, Parkhouse T, Yardley L, Yates J, Letley L, Ismail SA, Christensen H, French CE.   +15 more
europepmc   +1 more source

<i>German Million Children Cohort</i>: a historical birth cohort based on claims data to investigate the impact of immunisation and other early life factors on the risk of cancer and other diseases in childhood - cohort profile. [PDF]

BMJ Open
Brackmann LK, Mulanje L, Langbein S, Kollhorst B, Haug U, Ahrens W, Nagrani R, Marron M.   +7 more
europepmc   +1 more source

Evaluation of rotavirus, pneumococcal conjugate and human papillomavirus vaccination in four Pacific island countries: A cost-effectiveness modelling study. [PDF]

PLoS Med
Carvalho N, Watts E, Oliver VL, Clark A, Ozturk MH, Akauola S, Whelan C, Naseri T, Jenkins K, Mikkelsen-Lopez I, Lam KFK, Rabanal R, McLeod R, Jit M, Russell FM.   +14 more
europepmc   +1 more source

First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023. [PDF]

Euro Surveill
Foster K, Heymer EJ, Campbell H, Wilson E, Baldasera J, Lucidarme J, Clark SA, Bai X, Ahmad S, Borrow R, Ladhani SN.   +10 more
europepmc   +1 more source

Understanding adverse events following immunisation: evidence of vaccine safety and coincidental events from 3 years of surveillance. [PDF]

BMJ Paediatr Open
Mathew M, Sanathan SR, Ravi MD.
europepmc   +1 more source

Targeted assessment of prevalence of zero-dose and under-immunised children in Bangladesh. [PDF]

BMJ Glob Health
Jannat Z, Das H, Jannatul T, Ali MW, Alam N, Morgan C, Oliveras E, Corrêa GC, Reynolds HW, Uddin MJ.   +9 more
europepmc   +1 more source

Evaluating a Tailored Quality Improvement Intervention to Improve Vaccination Coverage in Sydney Residential Aged Care Facilities. [PDF]

Vaccines (Basel)
McGregor C, Tillman L, Maude L, Chee K, Swift C, McIndoe L, Ferson M, Goodger B, Wright K, Sheppeard V.   +9 more
europepmc   +1 more source

A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses. [PDF]

NPJ Vaccines
Zoest VP, Lee WS, Murdiyarso L, Burmas L, Pymm P, Esterbauer R, Kelly A, Kelly HG, Barber-Axthelm I, Cooney JP, Davidson KC, Dayton M, McAleese CE, Gillard M, Hughes K, Jones ML, Pellegrini M, Tham WH, Hughes B, Kent SJ, Wheatley AK, Juno JA, Tan HX.   +22 more
europepmc   +1 more source